---
schema_version: "secwatch.filing_event.v1"
accession: "0001819790-24-000138"
form_type: "8-K"
ticker: "TARS"
cik: "0001819790"
company_name: "Tarsus Pharmaceuticals, Inc."
filed_at: "2024-12-19T23:59:59+00:00"
generated_at: "2026-05-29T01:45:36.676824+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Tarsus Pharmaceuticals signs 10-year lease for new HQ in Irvine, CA

## Summary
- Lease for 59,626 sq. ft. at 17700 Laguna Canyon Road, Irvine, CA; term 120 months.
- Initial monthly base rent $211,672.30, with ~3% annual increases; 5-month rent abatement (~$656,756).
- Construction allowance up to ~$6 million; security deposit via $2.56M letter of credit.
- Lease commences ~11 months after signing or upon start of business activities at Premises.

## SEC filing metadata
- accession: 0001819790-24-000138
- form_type: 8-K
- ticker: TARS
- cik: 0001819790
- company_name: Tarsus Pharmaceuticals, Inc.
- filed_at: 2024-12-19T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 1.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1819790/000181979024000138/0001819790-24-000138-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1819790/000181979024000138/tars-20241216.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001819790-24-000138
- JSON: https://secwatch.observer/filing/0001819790-24-000138.json
- Plain text: https://secwatch.observer/filing/0001819790-24-000138.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.